Mert Nuhoglu's Highlights on '(3) Linden on X: "WHEN and WHY does $ABCL use AI? TL;DR: AbCellera is a leader in AI for biologic drug discovery. However, its differentiation in antibody discovery lies in its stacking capabilities—microfluidics, TetraGenetics, OrthoMap, Trianni, data—coupled with AI. To begin with, AI is a https://t.co/FtuN1bipcr" / X' | Glasp